Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Intra-Cellular Therapies Inc (NASDAQ:ITCI)

15.97
Delayed Data
As of Dec 08
 -0.24 / -1.48%
Today’s Change
10.80
Today|||52-Week Range
57.55
-70.31%
Year-to-Date

Today’s Trading

Previous close16.21
Today’s open16.67
Day’s range15.53 - 16.74
Volume730,981
Average volume (3 months)881,166
Market cap$691.0M
Dividend yield--
Data as of 12/08/2016

Growth & Valuation

Earnings growth (last year)-171.96%
Earnings growth (this year)+3.38%
Earnings growth (next 5 years)--
Revenue growth (last year)-84.17%
P/E ratioNM
Price/Sales21,235.50
Price/Book1.45

Competitors

 Today’s
change
Today’s
% change
SCMPSucampo Pharmaceutic...+0.27+1.84%
VNDAVanda Pharmaceutical...+0.50+3.25%
INSYINSYS Therapeutics I...-1.27-11.87%
MACKMerrimack Pharmaceut...+0.07+1.29%
Data as of 12/08/2016

Financials

Next reporting dateMarch 2, 2017
EPS forecast (this quarter)-$0.76
Annual revenue (last year)$91.4K
Annual profit (last year)-$104.8M
Net profit margin-114,698.50%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman, President &
Chief Executive Officer
Sharon Mates
CFO, Treasurer &
Vice President-Finance
Lawrence J. Hineline
Corporate headquarters
New York, New York

Forecasts


Search for Jobs